FLGT
Fulgent Genetics Inc
Price:  
25.70 
USD
Volume:  
387,067.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FLGT EV/EBITDA

-278.8%
Upside

As of 2026-11-12, the EV/EBITDA ratio of Fulgent Genetics Inc (FLGT) is -6.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLGT's latest enterprise value is 619.80 mil USD. FLGT's TTM EBITDA according to its financial statements is -94.20 mil USD. Dividing these 2 quantities gives us the above FLGT EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.3x - 14.5x 12.9x
Forward P/E multiples 10.6x - 13.1x 12.0x
Fair Price (41.79) - (48.58) (45.96)
Upside -262.6% - -289.0% -278.8%
25.70 USD
Stock Price
(45.96) USD
Fair Price

FLGT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-11-11 -6.58
2026-11-10 -6.60
2026-11-09 -6.70
2026-11-06 -6.06
2026-11-05 -4.71
2026-11-04 -4.98
2026-11-03 -4.90
2026-11-02 -4.88
2026-10-30 -5.23
2026-10-29 -5.51
2026-10-28 -5.47
2026-10-27 -5.25
2026-10-26 -5.13
2026-10-23 -5.09
2026-10-22 -5.07
2026-10-21 -5.10
2026-10-20 -5.16
2026-10-19 -5.09
2026-10-16 -5.02
2026-10-15 -5.42
2026-10-14 -5.34
2026-10-13 -5.35
2026-10-12 -5.46
2026-10-09 -5.53
2026-10-08 -5.29
2026-10-07 -5.22
2026-10-06 -5.22
2026-10-05 -5.72
2026-10-02 -5.46
2026-10-01 -5.41
2026-09-30 -5.60
2026-09-29 -5.62
2026-09-28 -5.69
2026-09-25 -5.65
2026-09-24 -5.48
2026-09-23 -5.40
2026-09-22 -5.51
2026-09-21 -5.48
2026-09-18 -5.52
2026-09-17 -5.56
2026-09-16 -5.50
2026-09-15 -5.41
2026-09-14 -5.24
2026-09-11 -5.19
2026-09-10 -5.10
2026-09-09 -5.03
2026-09-08 -5.12
2026-09-04 -5.00
2026-09-03 -4.98
2026-09-02 -5.08